Lactobacillus Acidophilus Regulates the Expression of MicroRNAs and Ameliorates the Symptoms of Acid-induced Ulcerative Colitis in Rats

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 195

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ZUMS-31-144_008

تاریخ نمایه سازی: 26 دی 1401

چکیده مقاله:

Background and Objective: Ulcerative colitis (UC) is an unknown recurrent intestinal disease and a common cause of gastrointestinal disorders, which may lead to colorectal cancer if not diagnosed and treated in a timely manner. The beneficial effects of several probiotics in diseases like inflammatory bowel disease (IBD) have been investigated, although their mechanisms have not been yet fully understood. In this study, we investigated the possible association between the changes in the levels of the expression of miRNAs and the anti-inflammatory activity of the L. acidophilus as a probiotic model in Wistar rats suffering the acid-induced UC. Materials and Methods: Twenty rats were randomly divided into four groups. To induce colitis, the rats were briefly anesthetized, and ۱ ml of acetic acid (۴%) was injected into their rectum using a Foley catheter, as explained previously.  L. acidophilus was given orally (۳×۱۰۸ CCU/ml) for ۱۰ days. The rats were monitored daily for clinical signs for ۱۰ days. Following euthanasia, the macroscopic and microscopic pathological lesions in the intestinal tissues were examined. Additionally, the total RNA from specimens were extracted, and the expression levels of mRNAs for cytokines, including TNFα, IL-۱β, IL-۶, IL-۱۰, IFN-γ, and the expression levels of miR-۱, miR-۱۵۵, miR-let۷d, and miR-۹۹a were determined using the qPCR method. Results: The clinical signs and pathological damages induced by acid were ameliorated in the rats receiving L. acidophilus compared with rats that did not receive it, as evidenced by improved clinical signs and results of immunohistochemistry and chemical assays. miRNAs, including miR-۱, miR-۹۹, miR-Let۷d and miR-۱۵۵ and changes in the expression of mRNAs, including TNFα, IL-۱β, IL-۶, IL-۱۰ and IFN-γ were significant. Changes in the amount of myeloperoxidase, nitrite oxide, and malondialdehyde were also significant (P ≤ ۰.۰۵). In pathological examination, immune cell infiltration and COX۲ were different in colitis and treatment groups. Conclusion: Therapeutic use of probiotics ameliorated UC by significantly changing the levels of miR-۱, miR-۹۹, miR-Let۷d and miR-۱۵۵.

نویسندگان

Mahvash Ghorbani

Dept. of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

Alireza Mahmoudian

Dept. of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

Seyyed Meysam AbtahiFroushani

Dept. of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

Abdolghaffar Ownagh

Dept. of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

Amir Tokmahchi

Dept. of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and ...
  • Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. ...
  • Aponte M, Murru N, Shoukat M. Therapeutic, prophylactic, and functional ...
  • Ailioaie LM, Litscher G. Probiotics, photobiomodulation, and disease management: Controversies ...
  • Llewellyn A, Foey A. Probiotic modulation of innate cell pathogen ...
  • Abdulkhaleq L, Assi M, Abdullah R, Zamri-Saad M, Taufiq-Yap Y, ...
  • Wang Z, Li S, Cao Y, et al. Oxidative stress ...
  • Kalla R, Ventham N, Kennedy N, et al. MicroRNAs: new ...
  • Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, et al. Intestinal anti-inflammatory ...
  • Valmiki S, Ahuja V, Paul J. MicroRNA exhibit altered expression ...
  • Luo X, Ranade K, Talker R, Jallal B, Shen N, ...
  • Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, et al. The administration ...
  • Frăţilă O, Iliaş TI. COX-۲ and Ki-۶۷ immunohistochemical markers in ...
  • Mahmoudian A, Markham PF, Noormohammadi AH, Browning GF. Kinetics of ...
  • Abtahi Froushani SM, Mashouri S. The beneficial effects of hypiran ...
  • Sun Y, Li L, Xie R, Wang B, Jiang K, ...
  • Hu T, Wang H, Xiang C, Mu J, Zhao X. ...
  • Peter ME. Targeting of mRNAs by multiple miRNAs: the next ...
  • Jung H, Kim JS, Lee KH, et al. Roles of ...
  • Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, ...
  • Grondin JA, Kwon YH, Far PM, Haq S, Khan WI. ...
  • Chen W, Zhuo M, Lu X, et al. SRC-۳ protects ...
  • Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc ...
  • Hou Y, Janczuk A, Wang P. Current trends in the ...
  • Krishn SR, Batra SK, Kaur S. Advances in miRNA-mediated mucin ...
  • Ahrne S, Johansson Hagslatt M-L. Effect of lactobacilli on paracellular ...
  • Cichon C, Sabharwal H, Rüter C, Schmidt MA. MicroRNAs regulate ...
  • Wan J, Xia L, Xu W, Lu N. Expression and ...
  • Hübenthal M. Phenotype prediction based on microRNA expression profiles: a ...
  • James JP, Riis LB, Malham M, Høgdall E, Langholz E, ...
  • Mueller AC, Sun D, Dutta A. The miR-۹۹ family regulates ...
  • Okayama H, Schetter AJ, Harris CC. MicroRNAs and inflammation in ...
  • Coskun M, Bjerrum JT, Seidelin JB, Troelsen JT, Olsen J, ...
  • Han C, Yu Z, Duan Z, Kan Q. Role of ...
  • نمایش کامل مراجع